J.M. Smucker's Jif peanut butter was linked to a Salmonella outbreak and made under insanitary conditions.
What happened
FDA and the Kentucky Cabinet for Health and Family Services Food Safety Branch jointly inspected the Lexington, KY facility from May 19, 2022, through June 9, 2022, as part of a multistate Salmonella Senftenberg outbreak investigation linked to ready-to-eat peanut butter. The outbreak included 21 people from 17 states, and the firm recalled all peanut butter made at the facility from October 1, 2021, to May 20, 2022. FDA found serious violations of food-safety manufacturing and control rules, including Salmonella in finished product and environmental samples, and conditions that let water enter roaster cooling air vents.
What FDA found
The hazard analysis did not evaluate Salmonella recontamination after roasting as a hazard needing a food-safety control.
21 CFR 117.130(c)(1)(ii)Environmental monitoring found Salmonella in the facility in 2018, 2019, and 2021, and the corrective actions did not stop it from recurring.
21 CFR 117.150(a)(2)(ii)Ready-to-eat peanut butter was prepared, packed, or held under conditions unclean enough to contaminate it.
section 402(a)(4) of the Act [21 U.S.C. § 342(a)(4)]The firm shipped peanut butter that FDA says was contaminated into interstate commerce.
section 301(a) of the Act [21 U.S.C. § 331(a)]The facility did not meet the food-safety control requirements of the rule.
section 301(uu) of the Act [21 U.S.C. § 331(uu)]
What FDA wants
FDA asks the firm to respond in writing within 15 working days with the specific steps taken to address the violations, an explanation of each step, and related documentation. The firm must also provide its current food-safety plan, including hazard analysis, and support for its proposed 'Hold' approach; if corrective actions cannot be completed in that time, it must state the reason and the time needed.
Who should pay attention
- food manufacturers with ready-to-eat low-moisture products
- brands that buy peanut butter or nut butters from contract manufacturers
- quality teams managing environmental monitoring for Salmonella
This is a summary. Read the original letter on fda.gov.